EP Magazine: Researchers, industry, and patient advocacy groups are driving efforts to facilitate early diagnosis and improve babies' long-term outlook. Commentary by Catherine Nester, BSN, Inozyme's VP of Physician and Patient Strategies.
PHARMAVOICE: Newborn screening is gaining prominence across the biopharma and healthcare industries amid efforts to detect and treat disease as early as possible.